
(more…)
Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
For me, this market has become an endurance contest, as we muddle through this brutal counter-trend rally. This post has a specific theme: relatively young stocks which had a horrid 2022 but bounced strongly in recent weeks. However, and this is what gains this admission to this post, they seem to have stalled, having executed the easy parts of their bounce. I wouldn’t touch any of these with a ten foot pole, but they’re interesting to watch.

Well, if I may offer the bears a faint wisp of hope – – and God knows we need it – – International Business Machines just had a massive failed bullish breakout pattern.

In the midst of this insane mega-rally this year, there’s one big stock that’s being left out in the cold, and that’s very-sketchy drug giant Pfizer (PFE):

Well, my friends, may God have mercy on my soul, but I have gone “all in” on what I’m hoping is something we will call “The Tesla Top” in retrospect (if not, we’ll have to come up with something clever like “The Final Reaming of Tim“, but we’ll see). In any case, trust that I’m focused on making your SlopeTalk experience as amazing as possible. Lots of tickets to conquer, Slopers!
